id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2007-N-0475-0016,FDA,FDA-2007-N-0475,FDA to Midodrine Application Holder - Letter,Other,LET-Letter,2009-08-13T04:00:00Z,2009,8,2009-08-13T04:00:00Z,,2009-08-13T19:55:28Z,,0,0,0900006480a08695
FDA-2007-N-0475-0017,FDA,FDA-2007-N-0475,"FDA to Mylan Pharmaceuticals, Inc. - Letter",Other,LET-Letter,2009-08-13T04:00:00Z,2009,8,2009-08-13T04:00:00Z,,2009-08-13T19:55:29Z,,0,0,0900006480a08fbf
FDA-2007-N-0475-0018,FDA,FDA-2007-N-0475,FDA to Midodrine Application Holder - Letter,Other,LET-Letter,2009-08-13T04:00:00Z,2009,8,2009-08-13T04:00:00Z,,2009-08-13T19:55:31Z,,0,0,0900006480a08fe1